Home
Home
About NYBA
About NYBA
Mission Statement
Board of Directors
Publication
Publication
Annual Reports
Speeches,Letters, Presentations
Annual Meeting Archive
NYBA Survey
Purchasing Consortium
Member Directory
Public Policy
Public Policy
NYBA Action
Industry Issues & Initiatives
Calendar
Calendar
Submit Event
NYBA Annual Meeting
Registration
Meeting Sponsor's Page
Sponsorships and Advertising Opportunities
Press Room
Press Release
Press Release
Press Release Archive
NYBA in the News
Member News
Member News
Stories pages
Life Sciences News(Businesswire)
Newsletter
Newsletter
Newsletter Archive
New York Biotech Center
New York Biotech Center
New York's Biotech Strengths
New York Biotech Initiatives
New York Biotech Initiatives
NYSTAR
Research & Development Where in New York
Research & Development Where in New York
Tech Transfer Directory
Academic Facilities
Incubators & Tech Parks
Sources of Funding
Government Economic Development Offices
Patent Advocacy Groups
NYBA Biotechnology Genealogy Database
NYBA's New York BioWeb
NYBA's New York BioWeb
Submit Link Form
Join NYBA
Join NYBA
Benefits of Membership
Application
Purchasing Consortium
Sponsorships and Advertising Opportunities
Member Directory
Careers
Search Openings
Search Resumes
Submit Resume
Submit Job
Job Profiles
Member Directory
Notices
Contact Us
Site Map
New York Biotechnology Association Announces Search For New Executive Director
The New York Biotechnology Association (NYBA), a not-for-profit trade...
06/ 29/ 2007
More…
New York Biotechnology Headlines
Today is November 21, 2009. All times in Eastern Time.
11/20/2009 - 03:02 PM
NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
11/20/2009 - 09:01 AM
EKR Therapeutics Named Private Company of the Year By New Jersey Technology Council
11/20/2009 - 08:30 AM
FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
11/20/2009 - 08:25 AM
European CHMP Formally Adopts Negative Opinion on Oncophage®
11/20/2009 - 08:04 AM
Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma
11/19/2009 - 04:36 PM
FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations
11/19/2009 - 10:49 AM
OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday, December 3rd
11/19/2009 - 09:19 AM
Enzon Presents Data at 2009 EORTC Meeting
11/18/2009 - 07:09 PM
FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
11/18/2009 - 01:01 PM
Guard Dog Brand Development Receives Three Silver Davey Awards in the Corporate Identity Category in the 5th Annual International Davey Awards for 2009
11/18/2009 - 12:50 PM
New York Biotechnology Association Requests Panel Proposals for NYBA 2010 Annual Meeting
11/18/2009 - 08:30 AM
Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases
11/18/2009 - 07:09 AM
Enzo Biochem’s Clinical Lab Enters Exclusive Agreement with GeneNews to Market Blood Test for Colorectal Cancer
11/18/2009 - 04:00 AM
Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)
11/18/2009 - 02:00 AM
Welch Allyn Advances Healthcare Delivery by Converging Traditional Diagnostics Devices with Latest in Electronic Connectivity Technology
11/17/2009 - 07:01 PM
GAVI’s Impact on Vaccine Market is Bringing Down Prices
11/17/2009 - 01:11 PM
Advaxis to Present at the LD MICRO Growth Conference
11/17/2009 - 09:00 AM
Advanced BioHealing Initiates Largest Prospective Clinical Trial for Venous Leg Ulcers Planned to Date
11/17/2009 - 08:00 AM
BioSante Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference
11/16/2009 - 04:27 PM
NovaDel Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2009
11/16/2009 - 03:24 PM
Enzon to Present Data at EORTC-NCI-AACR
11/16/2009 - 11:45 AM
Exact Sciences to Present at Lazard Healthcare Conference
11/16/2009 - 10:54 AM
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
11/16/2009 - 10:02 AM
Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
11/16/2009 - 09:35 AM
Aegerion Pharmaceuticals Announces Additional Lomitapide (AEGR-733) Phase III Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Safety Profile
1
2
Next »
Terms of Use
|
©2009 Business Wire
© 2007 New York Biotechnology Association
HOME
|
ABOUT NYBA
|
CONTACT US
|
NOTICES
|
SITE MAP
Website by Axxiem